Included in the formulation
АТХ:J.06.A.A.04 Botulinum antitoxin
Pharmacodynamics:Forms antibodies against botulinum toxin and tetanospazmina. Disinfects botulinum toxin, produced Clostridium botulinum and tetanospasmin, produced Clostridium tetani.
Pharmacokinetics:Not studied.
Indications:The drug is used for active immunization against botulism and tetanus.
XXI.Z20-Z29.Z27 The need for immunization against combinations of infectious diseases
I.A30-A49.A35 Other forms of tetanus
Contraindications:Individual intolerance. Acute infectious diseases, collagenoses, demyelinating diseases of the central nervous system.
Carefully:It is used with caution in chronic diseases in the acute stage.
Pregnancy and lactation:Recommendations for FDA not defined. There is no evidence of ingestion into breast milk.
Dosing and Administration:Subcutaneously in the subscapular region (1 cm from the lower angle of the scapula to the midline of the back), the course of immunization consists of three inoculations: a double vaccination with an interval of 25-30 days and revaccination after 6-9 months.Subsequent one-time revaccinations are performed according to indications every 5 years. Single dose - 1 ml. If it is necessary to extend the intervals, the next vaccination should be carried out as soon as possible.
Side effects:Allergic reactions.
Overdose:Cases of overdose are not described.
Interaction:Clinically significant interactions are not described.
Special instructions:Due to active immunization, antimicrobial, but antitoxic, immunity is produced.